Sharon Hanegraaf
Vice President of Regulatory Affairs / Argenica Therapeutics
| Rank | Company | # | |
|---|---|---|---|
| 110th | - | Argenica Therapeutics | $3.21m |
| 120th | - | icetana AI | $1.90m |
| 121st | - | CAQ Holdings | $1.89m |
| 122nd | - | EVE Health Group | $1.74m |
| 123rd | - | InteliCare | $1.58m |
| Rank | Company | 1 Yr | 5 Yr |
|---|---|---|---|
| 1635th | Argent BioPharma | -77.06% | -8.42% |
| 1636th | Lightning Minerals | -77.63% | 0% |
| 1637th | Argenica Therapeutics | -77.78% | 0% |
| 1638th | Sheffield Resources | -78.06% | -35.07% |
| 1639th | Alliance Aviation Services | -78.89% | -31.73% |
|
NEWS: Tagged in Board moves August 7, 2025 | 07 Aug 2025 |
|
NEW ROLE: Vice President of Regulatory Affairs, Argenica Therapeutics | 07 Aug 2025 |
Access to our data for Sharon Hanegraaf is only available to paid subscribers with Data & Insights access.
Data & Insights is Western Australia's most accurate and comprehensive business listings and searchable database.
Sharon Hanegraaf is linked to 1 organisation which is included in 1 list - Public Companies - Industrial WA.
To see the data you will need to Subscribe.